Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin

JOURNAL OF CHEMOTHERAPY

卷 33, 期 8, 页码 598-600

TAYLOR & FRANCIS LTD

meropenem-vaborbactam; fosfomycin; synergism; ceftazidime-avibactam resistance; KPC; Enterobacterales

Oncology Infectious Diseases Pathology Pharmacology & Pharmacy